Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas
Abstract Head and neck squamous cell carcinomas (HNSCC) induced by human papillomavirus (HPV) have increased recently in the US. However, the distinct alterations of molecules involved in the death pathways and drug effects targeting inhibitor of apoptosis proteins (IAPs) have not been extensively c...
Guardado en:
Autores principales: | Yi An, Jun Jeon, Lillian Sun, Adeeb Derakhshan, Jianhong Chen, Sophie Carlson, Hui Cheng, Christopher Silvin, Xinping Yang, Carter Van Waes, Zhong Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d665633856e14a8a985871ecd86fdb93 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prevalence of HPV in Mexican Patients with Head and Neck Squamous Carcinoma and Identification of Potential Prognostic Biomarkers
por: Galo Méndez-Matías, et al.
Publicado: (2021) -
mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
por: Joseph D. Coppock, et al.
Publicado: (2016) -
Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities
por: Daniela Cochicho, et al.
Publicado: (2021) -
Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women.
por: Fengyan Xu, et al.
Publicado: (2014) -
Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
por: V. La, et al.
Publicado: (2017)